期刊文献+

一种萘酰亚胺衍生物的合成及其体外抗癌活性测定

Synthesis of a naphthalimide derivative and evaluation of its in vitro antitumor activity
下载PDF
导出
摘要 合成了萘酰亚胺衍生物2-[2-(二甲基氨基)乙基]-6-2-(2-羟乙胺基)乙胺基-1H-苯并异喹啉-1,3(2H)-二酮;利用元素分析、核磁共振谱及质谱分析了其组成和结构;利用MTT法测定了其对人肝癌细胞(HepG2)、人乳腺癌细胞(MDA-MB-231)及人结肠癌细胞(HCT-116)的体外活性.结果表明,标题化合物的体外抗肿瘤活性优于对照品氨萘非特. A naphthalimide derivative, 2- { 2- (dimethylamino) ethyl }-6- { 2- ( 2-hydroxyethylamino) ethylamino}-lH-benzo [de] isoquinoline-1,3(2H)-dione, was synthesized. Its composition and structure were analyzed by elemental analysis, nuclear magnetic resonance spectrometry and mass spectrometry. Moreover, its in vitro antitumor activity against human hepatoma cell (HepG2), human breast cancer cells (MDA-MB-231) and human colon cancer cells (HCT- 116) was evaluated using MTT assay method. Results show that the title compound possesses better antitumor activiy than amonafide as the control.
出处 《化学研究》 CAS 2012年第3期5-6,15,共3页 Chemical Research
关键词 萘酰亚胺 衍生物 合成 抗肿瘤活性 测定 naphthalimide derivative synthesis antitumor activity evaluation
  • 相关文献

参考文献10

  • 1LV Min, XU Hui. Overview of naphthalimide analogs as anticancer agents[J]. Curr Med Chem, 2009, 16 (36) .4797- 4813.
  • 2INGRASSIA L, LEFRANC F, KISS R, et al. Naphthalimides and azonafides as promising anti-cancer agents[J]. Curr Med Chem, 2009, 16 (10)~ 1192-1213.
  • 3BRANA M F, CASTELLANO J M, ROLDAN C M, et al. Synthesis and mode(s) of action of a new series of imide deri- vatives of 3-nitro-l,8-naphthalic acid[J]. Cancer Chemother Pharmacol, 1980, 4: 61-66.
  • 4PEDUTO A, PAGANO B, PETRONZI C, et al. Design, synthesis, biophysical and biological studies of trisubstituted naphthalimides as C-quadruplex ligands[J].Bioorg Med Chem, 2011, 19 (21) : 6419-6429.
  • 5LIU Yan Ning, NORTON J T, WlTSCHI M A, et al. Methoxyethylamino-numonafide is an efficacious and minimally toxic amonafide derivative in murine models of human cancer[J]. Neoplasia, 2011, 13 (5): 453-460.
  • 6VAN QUAQUEBEKE E, MAHIEU T, DUMONT P, et al. 2,2,2-Trichloro-N-( { 2-[2-(dimethylamino) ethyl]-1,3-di- oxo-2,3-dihydro-1 H-benzo[-de3 isoquinolin-5-yl} earbamoyl) acetamide (UNBS3157), a novel nonhematotoxic naphthali- mide derivative with potent antitumor activity[J]. J Med Chem, 2007, 50 (17) ~ 4122-4134.
  • 7BRAIqA M F, RAMOS A. Naphthalimides as anticancer agents: synthesis and biological activity [J]. Curt Med Chem Anti Cancer Agents, 2001, 1(3): 237-255.
  • 8朱虹,丁健.萘酰亚胺类化合物作为抗肿瘤药物的研发现状[J].中国新药杂志,2007,16(10):742-747. 被引量:8
  • 9BRA1NA M F, CACHO M, GRADILLAS A, et al. Intercalators as anticancer drugs[J]. Curr Pharmac Design, 2001, 7.. 1745- 1780.
  • 10ZHUO Chen, XIN Liang, ZHANG Huang Ying, et aL A new class of naphthalimide based antitumor agents that inhibit topoisomerase ii and induce lysosomal membrane permeabilization and apoptosis[J]. J Med Chem, 2010, 53 (6): 2589- 2600.

二级参考文献39

  • 1BRANA MF, RAMOS A. Naphthalimides as anti-cancer agents:synthesis and biological activity[J]. Curr Med Chem Anti Cancer Agents, 2001, 1 (3) : 237 -255.
  • 2HSIANG YH, JIANG JB, LIU LF. Topoisomerase Ⅱ-mediated DNA cleavage by amonafide and its structural analogs [J].Mol Pharmacol, 1989, 36(3) : 371 -376.
  • 3DE ISABELLA P, ZUNINO F, CAPRANICO G. Base sequence determinants of amonafide stimulation of topoisomerase Ⅱ DNA cleavage [ J ]. Nucleic Acids Res, 1995, 23 ( 2 ) : 223 - 229.
  • 4SLUNT KM, GRACE JM, PEARSON RD, et al. Effect of mitonafide analogs on topoisomerase Ⅱ of Leishmania chagasi [ J ].Antimicrob Agents Chemother, 1996, 40 ( 3 ) : 706 - 709.
  • 5CHANG AY, TU ZN, SMITH JL, et al. Phase Ⅱ trim of gallium nitrate, amonafide and teniposide in metastatic non-small cell lung cancer. An Eastern Cooperative Oncology Group study(E2588) [J]. Invest New Drugs, 1995, 13(2) : 137 - 141.
  • 6LEAF AN, NEUBERG D, SCHWARTZ EL, et al. An ECOG phase Ⅱ study of amonafide in unresectable or recurrent carcinoma of the head and neck(PB390). Eastern Cooperative Oncology Group[J]. Invest New Drugs, 1997, 15(2) : 165 - 172.
  • 7ASBURY R, BLESSING JA, MCGUIRE WP, et al. A phase Ⅱ trial of amonafide in patients with endometrial cancer: a Gynecologic Oncology Group Study[J]. Am J Clin Oncol, 1998, 21(4) : 406 - 407.
  • 8TAYLOR SA, RANKIN C, TOWNSEND JJ, et al. Phase Ⅱ trial of amonafide in central nervous system tumors : a Southwest Oncology Group study[J]. Invest New Drugs, 2002, 20( 1 ) : 113 -115.
  • 9COSTANZA ME, BERRY D, HENDERSON IC, et al. Amonafide:An active agent in the treatment of previously untreated advanced breast cancer-a cancer and leukemia group B study (CALGB 8642) [J]. Clin Cancer Res, 1995, 1 (7) : 699 -704.
  • 10ALLEN SL, KOLITZ JE, LUNDBERG A, et al. Phase I study of amonafide + cytosine arabinoside (AraC) in patients with poor risk acute myeloid leukemia(AML) [ J]. J Clin Oncol, 2005,23[16 Suppl] : S6602.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部